Kidneys and Genito-Urinary System Diabetic Nephropathy

Table of Contents

RECENT HIGHLIGHTS AND CHANGES
--Recent Highlights and Changes
UPCOMING PATENT EXPIRES BY THERAPY AREA
Diabetic Nephropathy Pipeline Overview
--% of Projects (By Phase of Development)
--No. of Projects by Phase of Development
--Marketed Products Vs. Pipeline Products
Company Overview - Pipeline Projects
--Company Overview - Pipeline Projects

--Top Companies in late stage Diabetic Nephropathy Projects
--DiObex Inc.
--DAIICHI SANKYO COMPANY, LIMITED
--Exelixis Inc
--Eli Lilly & Co
--Kowa Company, Ltd.
--KAKEN PHARMACEUTICAL CO., LTD.
--Novartis AG
--NephroGenex, Inc.
--Pharmacopeia, Inc.
--Pfizer Inc
--Shire plc
--Sanofi-Aventis
--Takeda Pharmaceutical Company Limited
--Speedel
--Wyeth
--TransTech Pharma, Inc.

--Top Companies in early stage Diabetic Nephropathy Projects
--Dia-B Tech Ltd
--DeveloGen AG
--Eli Lilly & Co
--DiaKine Therapeutics, Inc.
--Genextra S.p.A.
--FibroGen, Inc.
--NephroGenex, Inc.
--Intercept Pharmaceuticals, Inc.
--Synvista Therapeutics, Inc.
--Pfizer Inc
--Warren Pharmaceuticals, Inc.
--TransTech Pharma, Inc.

Pipeline Revenue
--Pipeline Revenue
Full Pipeline View
--Pre Clinical Pipeline View
--Phase I Pipeline View
--Phase II Pipeline View
--Phase III Pipeline View
--Pending Approval Pipeline View
--On the Market Pipeline View